首页> 外文会议>China international nanoscience and technology symposium >Encapsulation of a potential anticancer drug within multifunctional poly(amidoamine) dendrimers for targeted inhibition of cancer cells
【24h】

Encapsulation of a potential anticancer drug within multifunctional poly(amidoamine) dendrimers for targeted inhibition of cancer cells

机译:在多功能聚(酰胺胺)树枝状大分子中封装潜在的抗癌药物,用于靶向抑制癌细胞

获取原文

摘要

Poly(amidoamine) (PAMAM) dendrimer-based multifunctional drug delivery carrier has been designed and synthesized by modifying the periphery primary amine groups of generation 5 (G5) PAMAM dendrimer with fluorescein isothiocyanate (FI, an imaging agent) and folic acid (FA, a targeting agent), followed by acetylation of the remaining amine groups (G5.NHAc-FI-FA). 2-Methoxyoestradiol (2-ME), a potential anticancer drug, was encapsulated within the synthesized multifunctional dendrimers. In vitro cytotoxicity results showed that G5.NHAc-FI-FA/2-ME complexes displayed similar therapeutic activity to that of pure drug. More importantly, G5.NHAc-FI-FA/2-ME complexes were able to specifically inhibit the growth of cancer cells overexpressing folic acid receptors. It indicates that multifunctional dendrimer nanodevices are promising drug carriers for targeted cancer therapy.
机译:聚(酰胺)基于树突式的多官能药物递送载体已经通过改变生成5(G5)PAMAM树枝状体的外围伯胺基团与荧光素异硫氰酸酯(FI,成像剂)和叶酸(FA,靶向剂),其次是剩余的胺基(G5.NAC-FI-FA)的乙酰化。 2-甲氧基雌二醇(2-ME),潜在的抗癌药物被包封在合成的多功能树枝状体内。体外细胞毒性结果表明,G5.NAC-Fa / 2-ME复合物与纯药物的治疗活性相似。更重要的是,G5.nhac-Fa / 2-Me复合物能够特异性地抑制过表达叶酸受体的癌细胞的生长。它表明,多功能树突纳米型纳米型是针对靶向癌症治疗的有前途的药物载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号